These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37930615)

  • 21. Development and Evaluation of Quantitative Immunoglobulin G Enzyme-Linked Immunosorbent Assay for the Diagnosis of Coronavirus Disease 2019 Using Truncated Recombinant Nucleocapsid Protein as Assay Antigen.
    Mutantu PN; Ngwe Tun MM; Nabeshima T; Yu F; Mukadi PK; Tanaka T; Tashiro M; Fujita A; Kanie N; Oshiro R; Takazono T; Imamura Y; Hirayama T; Moi ML; Inoue S; Izumikawa K; Yasuda J; Morita K
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays.
    Wang Q; Du Q; Guo B; Mu D; Lu X; Ma Q; Guo Y; Fang L; Zhang B; Zhang G; Guo X
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance estimation of two in-house ELISA assays for COVID-19 surveillance through the combined detection of anti-SARS-CoV-2 IgA, IgM, and IgG immunoglobulin isotypes.
    Ramírez-Reveco A; Velásquez G; Aros C; Navarrete G; Villarroel-Espíndola F; Navarrete M; Fica A; Plaza A; Castro N; Verdugo C; Acosta-Jamett G; Verdugo CC
    PLoS One; 2023; 18(2):e0270388. PubMed ID: 36745590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2.
    Yadegari H; Mohammadi M; Maghsood F; Ghorbani A; Bahadori T; Golsaz-Shirazi F; Zarnani AH; Salimi V; Jeddi-Tehrani M; Amiri MM; Shokri F
    Anal Biochem; 2023 Apr; 666():115079. PubMed ID: 36754135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test.
    Kulkarni R; Shrivastava S; Patil HP; Kore P; Rane P; Palkar S; Lalwani S; Mishra AC; Arankalle VA
    Indian J Med Res; 2021 May; 153(5&6):658-664. PubMed ID: 34145085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
    Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplexed flow cytometric approach for detection of anti-SARS-CoV-2 IgG, IgM and IgA using beads covalently coupled to the nucleocapsid protein.
    Zattoni IF; Huergo LF; Gerhardt ECM; Nardin JM; Dos Santos AMF; Rego FGM; Picheth G; Moure VR; Valdameri G
    Lett Appl Microbiol; 2022 Jun; 74(6):863-872. PubMed ID: 35148433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection.
    Yu F; Le MQ; Inoue S; Hasebe F; Parquet Mdel C; Morikawa S; Morita K
    Clin Vaccine Immunol; 2007 Feb; 14(2):146-9. PubMed ID: 17202310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endogenous factors affecting the detection of serum SARS-CoV-2 IgG/IgM antibodies by ELISA.
    Liu W; Long X; Wan K; Yin M; Yin Y; Zhang B; Li L; Song Y
    J Med Virol; 2022 May; 94(5):1976-1982. PubMed ID: 34967441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2.
    Liu PP; Zong Y; Jiang SP; Jiao YJ; Yu XJ
    ACS Omega; 2021 Apr; 6(14):9667-9671. PubMed ID: 33869946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of two SARS-CoV-2 IgG/IgM Rapid Tests in Capillary Blood Samples.
    Lee NY; Ham JY; Hwang N; Song KE
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
    Tozetto-Mendoza TR; Kanunfre KA; Vilas-Boas LS; Sanchez Espinoza EP; Paião HGO; Rocha MC; de Paula AV; de Oliveira MS; Zampelli DB; Vieira JM; Buss L; Costa SF; Sabino EC; Witkin SS; Okay TS; Mendes-Correa MC
    J Virol Methods; 2021 Apr; 290():114064. PubMed ID: 33453299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods.
    Emmerich P; von Possel R; Hemmer CJ; Fritzsche C; Geerdes-Fenge H; Menge B; Messing C; Borchardt-Lohölter V; Deschermeier C; Steinhagen K
    J Med Virol; 2021 Oct; 93(10):5816-5824. PubMed ID: 34061367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.
    Nilsson AC; Holm DK; Justesen US; Gorm-Jensen T; Andersen NS; Øvrehus A; Johansen IS; Michelsen J; Sprogøe U; Lillevang ST
    Int J Infect Dis; 2021 Feb; 103():381-388. PubMed ID: 33310021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
    Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein.
    Thudium RF; Stoico MP; Høgdall E; Høgh J; Krarup HB; Larsen MAH; Madsen PH; Nielsen SD; Ostrowski SR; Palombini A; Rasmussen DB; Foged NT
    J Clin Microbiol; 2021 Sep; 59(10):e0100121. PubMed ID: 34260271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer.
    Cameron A; Bohrhunter JL; Porterfield CA; Mangat R; Karasick MH; Pearson Z; Angeloni S; Pecora ND
    Microbiol Spectr; 2022 Apr; 10(2):e0250721. PubMed ID: 35389244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.